A Phase 1 study of BAY3563254 in metastatic castration-resistant prostate cancer

Recruiting Phase 1 NCT06217822

Study Description

A First-in-Human Study of a Novel Radiation Therapy for Advanced Prostate Cancer

Study Details

Registry ID:
NCT06217822
Conditions:
Advanced Metastatic Castration-resistant Prostate Cancer, Prostate Specific Membrane Antigen (PSMA) Expression
Phase:
Phase 1
Target Enrollment:
198 participants
Start Date:
Healthy Volunteers:
No

Study Locations (67 sites)

Interested in Participating?

Check your eligibility and learn more about this study on TrialScreen.

View full study details and check eligibility →